Journal for ImmunoTherapy of Cancer (Nov 2023)
722 Evaluation of the effects of pembrolizumab alone and in combination(s) with MDSC-targeting agents MK-0482 and MK-4830 on the native cancer patient TME via functional spatial profiling (CIVO®)
- Michael Wagner,
- Kenneth Gundle,
- Wendy Jenkins,
- Cherie-Ann Nathan,
- Karthik Rajasekaran,
- Jeffrey Houlton,
- Daniel Clayburgh,
- Elyse Brinkmann,
- John Pang,
- Annemieke Van Zante,
- Jessica Davis,
- Connor Burns,
- Jason Frazier,
- Emily Beirne,
- Angela Merrell,
- Bre Mills,
- Jonathan Derry,
- Hanrong Sang,
- Atticus Turner,
- Marc Grenley,
- Nathan Schauer,
- Richard Klinghoffer
Affiliations
- Michael Wagner
- 4University of Washington, Seattle, WA, USA
- Kenneth Gundle
- 1Oregon Health and Science University, Portland, OR, USA
- Wendy Jenkins
- 8Presage Biosciences, Inc., Seattle, WA, USA
- Cherie-Ann Nathan
- 5Louisiana State University Health Shreveport, Shreveport, LA, USA
- Karthik Rajasekaran
- 2University of Pennsylvania, Philadelphia, PA, USA
- Jeffrey Houlton
- 3Sarah Cannon Cancer Institute, Charleston, SC, USA
- Daniel Clayburgh
- 1Oregon Health and Science University, Portland, OR, USA
- Elyse Brinkmann
- 4University of Washington, Seattle, WA, USA
- John Pang
- 5Louisiana State University Health Shreveport, Shreveport, LA, USA
- Annemieke Van Zante
- 6University of California San Francisco, San Francisco, CA, USA
- Jessica Davis
- 7Indiana University School of Medicine, Indianapolis, IN, USA
- Connor Burns
- 8Presage Biosciences, Inc., Seattle, WA, USA
- Jason Frazier
- 8Presage Biosciences, Inc., Seattle, WA, USA
- Emily Beirne
- 8Presage Biosciences, Inc., Seattle, WA, USA
- Angela Merrell
- 8Presage Biosciences, Inc., Seattle, WA, USA
- Bre Mills
- 8Presage Biosciences, Inc., Seattle, WA, USA
- Jonathan Derry
- 8Presage Biosciences, Inc., Seattle, WA, USA
- Hanrong Sang
- 8Presage Biosciences, Inc., Seattle, WA, USA
- Atticus Turner
- 8Presage Biosciences, Inc., Seattle, WA, USA
- Marc Grenley
- 8Presage Biosciences, Inc., Seattle, WA, USA
- Nathan Schauer
- 8Presage Biosciences, Inc., Seattle, WA, USA
- Richard Klinghoffer
- 8Presage Biosciences, Inc., Seattle, WA, USA
- DOI
- https://doi.org/10.1136/jitc-2023-SITC2023.0722
- Journal volume & issue
-
Vol. 11,
no. Suppl 1
Abstract
No abstracts available.
